We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical reforms in Japan may encourage greater use of generic drugs, but regulatory and cultural barriers still present obstacles to foreign manufacturers seeking to break into the Japanese generic market, an analyst said.